Harrow Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on April 5, 2021, regarding an event that occurred on March 30, 2021. The Company is a Delaware corporation with its principal executive offices in Nashville, Tennessee, and its common stock trades on The NASDAQ Global Market under the symbol "HROW".
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed relates to debt reduction:
- Debt Reduction: Full forgiveness of a Paycheck Protection Program (PPP) loan.
- Loan Principal: $1,967,100.
- Interest: All accrued interest was also forgiven.
- Lender: Renasant Bank.
Material Changes
The material change reported is the termination of a material definitive agreement via loan forgiveness. On March 30, 2021, the Company received notice from the U.S. Small Business Administration that the full balance of the PPP loan, originally entered into in April 2020, was forgiven in accordance with the CARES Act. This eliminates the Company's obligation to repay the principal and accrued interest.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks or contingencies beyond the resolution of the PPP loan obligation. No unusual items were reported other than the loan forgiveness event.
Key Facts for Investor Verification
- Verify the impact of the $1,967,100 loan forgiveness on the Company's balance sheet and potential tax implications.
- Confirm the date of the forgiveness notice (March 30, 2021) against the Company's subsequent financial reporting.
- Review the Company's remaining debt obligations and liquidity position post-forgiveness.